Alcentra Capital Corp. (NASDAQ:ABDC) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Monday.

A number of other research firms have also recently weighed in on ABDC. DA Davidson started coverage on shares of Alcentra Capital Corp. in a research note on Wednesday, July 5th. They issued a “buy” rating and a $15.00 target price on the stock. Keefe, Bruyette & Woods set a $13.00 target price on shares of Alcentra Capital Corp. and gave the company a “hold” rating in a research report on Sunday, August 6th. Raymond James Financial, Inc. lowered shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and decreased their price target for the stock from $16.00 to $14.00 in a research note on Monday, July 17th. Finally, TheStreet lowered shares of Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research note on Monday, July 24th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $13.50.

Shares of Alcentra Capital Corp. (ABDC) traded down 1.96% during trading on Monday, hitting $10.50. The stock had a trading volume of 121,590 shares. Alcentra Capital Corp. has a 52 week low of $10.20 and a 52 week high of $14.73. The company has a market capitalization of $149.57 million, a price-to-earnings ratio of 21.88 and a beta of 0.74. The company’s 50 day moving average price is $10.76 and its 200 day moving average price is $12.68.

ILLEGAL ACTIVITY NOTICE: “Alcentra Capital Corp. (ABDC) Lifted to “Buy” at ValuEngine” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/02/alcentra-capital-corp-abdc-lifted-to-buy-at-valuengine.html.

In other Alcentra Capital Corp. news, Director Steven H. Reiff purchased 11,668 shares of the stock in a transaction dated Monday, August 7th. The shares were bought at an average price of $10.72 per share, with a total value of $125,080.96. Following the completion of the transaction, the director now directly owns 7,000 shares in the company, valued at approximately $75,040. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 4.96% of the company’s stock.

Several large investors have recently bought and sold shares of ABDC. Oppenheimer & Co. Inc. boosted its holdings in shares of Alcentra Capital Corp. by 4.4% in the second quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock worth $178,000 after acquiring an additional 550 shares during the period. Wells Fargo & Company MN raised its stake in shares of Alcentra Capital Corp. by 4.9% during the 1st quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock valued at $396,000 after purchasing an additional 1,354 shares during the period. Carnegie Capital Asset Management LLC raised its stake in shares of Alcentra Capital Corp. by 8.1% during the 2nd quarter. Carnegie Capital Asset Management LLC now owns 20,011 shares of the asset manager’s stock valued at $232,000 after purchasing an additional 1,500 shares during the period. Confluence Investment Management LLC raised its stake in shares of Alcentra Capital Corp. by 2.7% during the 2nd quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock valued at $2,847,000 after purchasing an additional 5,566 shares during the period. Finally, Royal Bank of Canada raised its stake in shares of Alcentra Capital Corp. by 1,948.4% during the 2nd quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock valued at $120,000 after purchasing an additional 8,378 shares during the period. Hedge funds and other institutional investors own 31.49% of the company’s stock.

About Alcentra Capital Corp.

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Analyst Recommendations for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Stock Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related stocks with our FREE daily email newsletter.